Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
1 study found for:    NCT00676507
Show Display Options
Rank Status Study
1 Completed Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy
Conditions: Lung Neoplasm;   Carcinoma Non-small Cell Lung Cancer Stage IIIA;   Carcinoma Non-small Cell Lung Cancer Stage IIIB;   Carcinoma Non-small Cell Lung Cancer Stage IV
Interventions: Biological: Lucanix™;   Other: Placebo Comparator

Study has passed its completion date and status has not been verified in more than two years.